載入...
PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed
Conventional chemotherapy for lung cancer exerts anti-tumor effects through cytotoxicity, and through immunologic regulation by reducing specific T cell subsets and inducing the expression of programmed death ligand 1 (PD-L1) on tumor cells. Even though pemetrexed has shown huge potential in combina...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5630412/ https://ncbi.nlm.nih.gov/pubmed/29029512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19973 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|